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The integrin reconstruction act
“I
n biology, you really know 
what you’re talking about when 
you can reconstruct a system 
synthetically,” says Mark Ginsberg from 
UC San Diego. That hasn’t been possible 
in the case of integrin activation—the 
process by which integrin adhesion recep-
tors gain an increased affi  nity for their 
extracellular matrix ligands. The activation 
mechanism has been highly controversial 
for more than a decade, partly because the 
phenomenon hasn’t been accurately reca-
pitulated with purifi   ed proteins in vitro. 
But a team of scientists has now success-
fully reconstructed the events leading to 
integrin activation, which may help settle 
some of the fi  eld’s major disputes (1).
Integrin activation occurs from the 
inside out: events in the cytoplasm change 
the behavior of the integrins’ extracellular 
domains (2). A key event is the binding of 
a protein called talin to the integrin- 
subunit’s cytoplasmic tail. According to 
different structural, genetic, and cell bio-
logical studies, talin binding may or may 
not be suffi  cient to activate the adhesion 
receptors—recent reports suggest that a 
family of proteins called kindlins may be 
required, too (3). It’s also 
unclear whether activa-
tion involves a change in 
integrin conformation, or 
whether receptor cluster-
ing  increases affi  nity  for 
the extracellular matrix. 
On top of that, the role of 
force in integrin activation 
has remained elusive, with 
some suggestions that ten-
sion may be required to pull 
integrins into an active conformation (4).
Ye et al. directly tested the contri-
bution of talin to integrin activation by 
reconstituting the process in vitro with pu-
rifi  ed integrins inserted into phospholipid 
liposomes. Addition of the head domain of 
talin—the key component for integrin acti-
vation—was suffi  cient to induce the integ-
rins to bind their ligand in greater amounts. 
Whereas kindlins may be involved in 
integrin activation in cells, it seems talin 
doesn’t need their help in vitro. However, 
the integrins must be membrane embedded, 
and mutating a phospholipid-binding site in 
talin reduced its ability to activate integrins 
in vitro. The group proposes that the mem-
brane helps orient the talin and its bound 
integrin- subunit to effect activation (5).
But what happens to integrins when 
they’re activated by talin in vitro? Do they 
undergo a conformational 
change or do they cluster 
together? They didn’t seem 
to be clustering on the lipo-
some surface, but to answer 
the question defi  nitively, Ye 
and colleagues immobilized 
single integrins in lipid nano-
discs—10–13-nm phospho-
lipid bilayers stabilized by a 
membrane scaffold protein. 
Again, the talin head was 
suffi  cient to increase ligand binding, even 
though electron microscopy (EM) revealed 
that individual integrins remained isolated 
in separate nanodiscs.
Thus, talin increases the affi  nity 
of single, unclustered integrins. It seems 
to do this by inducing a conformational 
change in integrin, so that its extracellular 
domain extends away from the membrane 
surface instead of forming a compact, 
bent shape. The team’s EM analysis of 
nanodisc-embedded integrins shows that 
talin shifts the adhesion receptor to a more 
extended conformation even in the absence 
of ligand or pulling forces. “This is the fi  rst 
direct proof that talin binding alone activates 
a single integrin and shifts its equilibrium 
toward the extended form,” says Ginsberg.
The establishment of an in vitro sys-
tem that recreates integrin activation with 
purifi  ed proteins should help solve many 
more questions about the process. How is 
talin regulated? Do changes in membrane 
lipid composition affect activation? And 
what exactly do kindlins do? “Genetics 
tells us that they’re doing something,” 
explains Ginsberg. “Are they working 
directly to activate integrins, or do they 
have a more indirect effect? With this 
system, we can add back proteins and 
figure out who is doing what to whom.”
The ultimate goal is larger still. “I 
think this is the first step toward the 
synthetic recreation of integrin-based 
focal adhesions,” Ginsberg says. “That’s 
something that a lot of people will be 
trying to do in the next fi  ve years.” 
1. Ye, F., et al. 2010. J. Cell Biol. doi:10.1083/
jcb.200908045.
2. Hynes, R.O. 2002. Cell. 110:673–687.
3. Moser, M., et al. 2009. Science. 324:895–899.
4. Zhu, J., et al. 2008. Mol. Cell. 32:849–861.
5. Wegener, K.L., et al. 2007. Cell. 128:171–182.
Feng Ye (above) and colleagues from Florida State University, the University of Illinois, 
The Burnham Institute, and UC San Diego resolve several long-standing controversies over the 
mechanism by which integrin adhesion receptors are activated to bind their extracellular matrix 
ligands with higher afﬁ  nity. The researchers recreated the process in vitro by inserting single 
integrin molecules into phospholipid nanodiscs (top row). The cytoplasmic protein talin was 
sufﬁ   cient to activate these integrins, causing them to adopt an extended conformation 
(bottom right) capable of binding extracellular matrix (bottom left).







Recreating integrin activation in vitro resolves several long-running controversies.
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